Biopharmaceuticals Advisory Board
New Leaf works with a broad range of industry advisors to support its investment activities in therapeutics. We work with a large group of advisors that includes contacts from industry and academia that each of the investment professionals within the firm has cultivated through their own professional and academic experiences. New Leaf has engaged several leading therapeutics experts as advisors for specific areas of interest. Some examples of advisors who have been working closely with New Leaf recently include the following:
Principal Consultant, Chuang-Stein Consulting
Former Vice President, Head of Statistical Research and Consulting Center, Pfizer
Elias Reichel, M.D.
Associate Professor and Vice Chair of the Department of Ophthalmology
Tufts University School of Medicine
Edward Skolnik, M.D.
Norman S. Wikler Professor of Medicine
New York University Medical Center